Continence Reports最新文献

筛选
英文 中文
Bladder dysfunction caused by tuberculosis: A historical review 结核病导致的膀胱功能障碍:历史回顾
Continence Reports Pub Date : 2024-05-29 DOI: 10.1016/j.contre.2024.100052
Etienne Cuénant , Philip Van Kerrebroeck
{"title":"Bladder dysfunction caused by tuberculosis: A historical review","authors":"Etienne Cuénant ,&nbsp;Philip Van Kerrebroeck","doi":"10.1016/j.contre.2024.100052","DOIUrl":"https://doi.org/10.1016/j.contre.2024.100052","url":null,"abstract":"<div><p>Tuberculosis has become an infrequent disease in Western society, hence has tuberculosis of the bladder. However, when tuberculosis was prevalent, urogenital tuberculosis and tuberculosis of the bladder could be the consequence if untreated, and were responsible for severe bladder dysfunction. Before antibiotic treatment became available, chronic bladder tuberculosis caused irreversible damage and often necessitated bladder reconstruction or even cystectomy. The specific antibiotic treatment of tuberculosis eradicated bladder dysfunction caused by tuberculosis. We aim to review the history of urogenital tuberculosis and the consequent dysfunction of the bladder based on existing literature.</p></div>","PeriodicalId":100330,"journal":{"name":"Continence Reports","volume":"11 ","pages":"Article 100052"},"PeriodicalIF":0.0,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772974524000061/pdfft?md5=7047a93bab76027ff6cab3c9cdb00fb5&pid=1-s2.0-S2772974524000061-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141314836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sterile abscess formation following periurethral injections with synthetic polycaprolactone microspheres suspended in a carboxymethylcellulose gel (Urolon®): A case report 尿道周围注射悬浮在羧甲基纤维素凝胶(Urolon®)中的合成聚己内酯微球后形成无菌脓肿:病例报告
Continence Reports Pub Date : 2024-05-09 DOI: 10.1016/j.contre.2024.100050
J.E.M. Budo, J.P. Heesakkers
{"title":"Sterile abscess formation following periurethral injections with synthetic polycaprolactone microspheres suspended in a carboxymethylcellulose gel (Urolon®): A case report","authors":"J.E.M. Budo,&nbsp;J.P. Heesakkers","doi":"10.1016/j.contre.2024.100050","DOIUrl":"10.1016/j.contre.2024.100050","url":null,"abstract":"<div><p>Periurethral injection of bulking agents is a technique used to treat urinary incontinence due to stress incontinence, preferably caused by intrinsic sphincter deficiency. The variety of the nature of existing bulking agents leads to different success rates and complications. This case report describes the formation of pseudo-abscesses after periurethral injections with a bioresorbable implant consisting of synthetic polycaprolactone microspheres suspended in a carboxymethylcellulose gel carrier.</p></div>","PeriodicalId":100330,"journal":{"name":"Continence Reports","volume":"10 ","pages":"Article 100050"},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772974524000048/pdfft?md5=ec75410be569c8257dcd2f18c799488b&pid=1-s2.0-S2772974524000048-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141058437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel clinical classification for male urinary incontinence: MI-CRONS 男性尿失禁的新型临床分类:MI-CRONS
Continence Reports Pub Date : 2024-05-09 DOI: 10.1016/j.contre.2024.100051
George Kasyan , Bagrat Grigoryan , Dmitry Pushkar
{"title":"A novel clinical classification for male urinary incontinence: MI-CRONS","authors":"George Kasyan ,&nbsp;Bagrat Grigoryan ,&nbsp;Dmitry Pushkar","doi":"10.1016/j.contre.2024.100051","DOIUrl":"https://doi.org/10.1016/j.contre.2024.100051","url":null,"abstract":"<div><h3>Introduction:</h3><p>The aim of this study is to develop a new simple and practical classification of male urinary incontinence (UI) based on the clinical features and type of urinary incontinence.</p></div><div><h3>Materials &amp; methods:</h3><p>MI-CRONS classification is a system based on severity of incontinence and patients’ characteristics. Clinical evaluation of incontinence severity is based on preservation of voiding, proportion of void/lost urine, absorbable device usage, level of physical efforts that causes urine loss and nocturnal incontinence. Following patients’ characteristics of patients were included in classification system: history of radical prostatectomy, history of pelvic radiation, surgery for prostatic obstruction, neurogenic or non-neurogenic bladder disorders, and urethral strictures and disorders. This MI-CRONS classification system uses five uppercase Latin letters as follows: Male Incontinence — Cancer, Radiation, Obstruction, Neurogenic, Stricture. The classification could be used for stress, urgency, and mixed UI forms.</p></div><div><h3>Results:</h3><p>The new MI-CRONS classification system was applied to 85 of 86 patients evaluated in this retrospective study. Patients were classified by MI-CRONS to estimate an inclusiveness and complicity of proposed classification only. One patient was not classified using the new MI-CRONS classification due to history of bladder exstrophy and augmentation cystoplasty. Most of the men studied had a stress form of urinary incontinence and the most common types were 2 (n = 18) and 3 (n = 17) after radical prostatectomy.</p></div><div><h3>Conclusion:</h3><p>The MI-CRONS has demonstrated prompt potential for classifying male incontinence of any type. The classification is a simple tool to describe these patients and could be useful for daily practice and clinical trials. Although further multicenter studies are needed to evaluate the predictive value of this tool. A Delphi consensus would be proposed with international experts for the further development of MI-CRONS.</p></div>","PeriodicalId":100330,"journal":{"name":"Continence Reports","volume":"10 ","pages":"Article 100051"},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S277297452400005X/pdfft?md5=f613bd39056ae9a946f9fec66a8028b7&pid=1-s2.0-S277297452400005X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140951939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The durability of filter cap for OT-Balloon catheter, a novel urethral catheter for intermittent balloon catheterization 用于间歇性球囊导尿的新型尿道导管 OT-Balloon 导管过滤帽的耐用性
Continence Reports Pub Date : 2024-05-04 DOI: 10.1016/j.contre.2024.100049
Tomofumi Watanabe , Motoo Araki , Takuya Sadahira
{"title":"The durability of filter cap for OT-Balloon catheter, a novel urethral catheter for intermittent balloon catheterization","authors":"Tomofumi Watanabe ,&nbsp;Motoo Araki ,&nbsp;Takuya Sadahira","doi":"10.1016/j.contre.2024.100049","DOIUrl":"https://doi.org/10.1016/j.contre.2024.100049","url":null,"abstract":"<div><h3>Objective:</h3><p>The OT-Balloon Catheter is a novel urethral catheter designed for intermittent balloon catheterization. It has a filter permeable to gases but not liquids, enabling patients to confirm adequate catheterization without the flow of urine. This study examined the characteristics of the filter cap for OT-Balloon Catheter by repeatedly exposing filters to urine samples in 2 different conditions.</p></div><div><h3>Methods:</h3><p>Urine samples were collected from 10 patients who required clean intermittent catheterization and visited Okayama University Hospital in 2023. Filters of the cap for OT-Balloon Catheter were exposed to urine samples for 30 times under 2 conditions, as follows: condition A, filters were rinsed with running water after exposure to urine; condition B, filters were never rinsed throughout the experiment. The permeability of the filters during and after the exposure was examined. The filter surface was also analyzed by stereomicroscopy.</p></div><div><h3>Results:</h3><p>None of the filters were blocked after treatment in condition A. More than 50% of the filters remained permeable after 20 and 30 exposures even in condition B. Long-term storage did not lead to increased rates of blockage. Microscopic examination found minimal urine stains on the surface of filters under condition B.</p></div><div><h3>Conclusion:</h3><p>The filter cap for OT-Balloon Catheter was resistant to blockage and maintained permeability after exposure to urine when adequately rinsed, and also when never rinsed after exposure to most samples. The durable permeability of the filter enables patients to achieve rapid, safe, and easy intermittent balloon catheterization.</p></div>","PeriodicalId":100330,"journal":{"name":"Continence Reports","volume":"10 ","pages":"Article 100049"},"PeriodicalIF":0.0,"publicationDate":"2024-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772974524000036/pdfft?md5=e662ac292e2f002269604f07161018df&pid=1-s2.0-S2772974524000036-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140902380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Carbamazepine in the treatment of refractory secondary enuresis: A case report 卡马西平治疗难治性继发性遗尿症的疗效:病例报告
Continence Reports Pub Date : 2024-04-23 DOI: 10.1016/j.contre.2024.100048
Andretta Elena , Rosato Eleonora , Zuliani Cristina , Finazzi Agrò Enrico
{"title":"Effectiveness of Carbamazepine in the treatment of refractory secondary enuresis: A case report","authors":"Andretta Elena ,&nbsp;Rosato Eleonora ,&nbsp;Zuliani Cristina ,&nbsp;Finazzi Agrò Enrico","doi":"10.1016/j.contre.2024.100048","DOIUrl":"10.1016/j.contre.2024.100048","url":null,"abstract":"<div><p>A 42-year-old woman was referred by neurology colleagues to our outpatient urology clinics. She presented with a non-monosymptomatic secondary enuresis, which started at 20 years of age When she was twenty-two she presented a single episode of a generalised tonic-clonic seizure, and she was treated with Carbamazepine (CBZ) with resolution of enuresis that reappeared when CBZ was stopped. Therefore, a video-EEG was performed, which documented an episode of enuresis during stage 1 of non-REM sleep without epileptic discharges and made it difficult for the patient to reach the deeper stages of sleep. According to these findings, the epileptic genesis of the enuresis was ruled out. A urodynamic invasive study was performed, and a normal active bladder associated with sleep disturbances was diagnosed as the combined cause of the non-monosymptomatic secondary nocturnal enuresis.</p><p>Behavioural therapy and/or antimuscarinic treatments, alone or in combination, were used without success. Then the patient restarted CBZ at a low dose (200 mg/day), and a significant reduction of enuresis episodes (1 wet night every 9–10) was obtained with no changes in the bladder diary.</p><p>CBZ effectiveness in such a case on an overactive bladder (OAB) could depend on its modulating effect in the central nervous system.</p></div>","PeriodicalId":100330,"journal":{"name":"Continence Reports","volume":"10 ","pages":"Article 100048"},"PeriodicalIF":0.0,"publicationDate":"2024-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772974524000024/pdfft?md5=f651adaa32d43bc20791989f8dbe9f03&pid=1-s2.0-S2772974524000024-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140759818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum to “COVID-19- associated Guillain–Barrè Syndrome and Urinary Dysfunction: A case report” [Cont. Rep. 4 (2022) 100017] COVID-19相关格林-巴利综合征和排尿功能障碍:病例报告" [Cont. Rep. 4 (2022) 100017] 更正
Continence Reports Pub Date : 2024-03-01 DOI: 10.1016/j.contre.2023.100045
Marilena Gubbiotti , Wally Mahfouz , Anastasios D. Asimakopoulos , Ludovica Durante , Giacomo Maria Pirola , Daniele Castellani , Emanuele Rubilotta
{"title":"Erratum to “COVID-19- associated Guillain–Barrè Syndrome and Urinary Dysfunction: A case report” [Cont. Rep. 4 (2022) 100017]","authors":"Marilena Gubbiotti ,&nbsp;Wally Mahfouz ,&nbsp;Anastasios D. Asimakopoulos ,&nbsp;Ludovica Durante ,&nbsp;Giacomo Maria Pirola ,&nbsp;Daniele Castellani ,&nbsp;Emanuele Rubilotta","doi":"10.1016/j.contre.2023.100045","DOIUrl":"10.1016/j.contre.2023.100045","url":null,"abstract":"","PeriodicalId":100330,"journal":{"name":"Continence Reports","volume":"9 ","pages":"Article 100045"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772974523000261/pdfft?md5=47ef1f03e196129d4c70a8c4e98d46a0&pid=1-s2.0-S2772974523000261-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138608291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-incision vaginal mesh insertion for recurrent vaginal vault prolapse after radical cystectomy and radical hysterectomy with irradiation: A case report 单切口阴道网片植入术治疗根治性膀胱切除术和根治性子宫切除术加照射术后复发性阴道穹隆脱垂:病例报告
Continence Reports Pub Date : 2024-02-01 DOI: 10.1016/j.contre.2024.100047
Zoltan Nemeth , Roxana Schmidt , Balint Farkas
{"title":"Single-incision vaginal mesh insertion for recurrent vaginal vault prolapse after radical cystectomy and radical hysterectomy with irradiation: A case report","authors":"Zoltan Nemeth ,&nbsp;Roxana Schmidt ,&nbsp;Balint Farkas","doi":"10.1016/j.contre.2024.100047","DOIUrl":"https://doi.org/10.1016/j.contre.2024.100047","url":null,"abstract":"<div><p>A 74-year-old female patient five month after radical robot assisted cystectomy (RC) with ileal conduit (IC) presented to our department with stage 4 symptomatic vaginal prolapse and anterior enterocele (AE). In the medical history 43 years ago radical hysterectomy (Piver 3) was revealed followed by postoperative irradiation and brachytherapy, due to invasive cervical cancer. A total colpocleisis was carried out as a first line therapy. A recurrence occurred 8 months after the first surgery. We used a customized single-incision vaginal mesh for the relapse operation. The patient has been symptomless for 50 months. We believe that vaginal irradiation is a rare but significant risk factor for the development of anterior enterocele after RC with IC and single-incision tailored vaginal mesh insertion for symptomatic anterior enterocele after radical cystectomy and radical hysterectomy with irradiation may be a long-term surgical solution.</p></div>","PeriodicalId":100330,"journal":{"name":"Continence Reports","volume":"9 ","pages":"Article 100047"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772974524000012/pdfft?md5=cffb951a50687b93268b46f49cb67ed6&pid=1-s2.0-S2772974524000012-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139733244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum to: “Neurogenic voiding dysfunction induced by vitamin B6 overdose” [Continence Rep. 1 (2022) 100004] 勘误:"维生素 B6 过量诱发的神经源性排尿功能障碍》[Continence Rep. 1 (2022) 100004] 更正
Continence Reports Pub Date : 2023-12-01 DOI: 10.1016/j.contre.2023.100038
T. Van den Broeck , B. Crul , J.P. Heesakkers
{"title":"Erratum to: “Neurogenic voiding dysfunction induced by vitamin B6 overdose” [Continence Rep. 1 (2022) 100004]","authors":"T. Van den Broeck ,&nbsp;B. Crul ,&nbsp;J.P. Heesakkers","doi":"10.1016/j.contre.2023.100038","DOIUrl":"https://doi.org/10.1016/j.contre.2023.100038","url":null,"abstract":"","PeriodicalId":100330,"journal":{"name":"Continence Reports","volume":"8 ","pages":"Article 100038"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772974523000182/pdfft?md5=c4f20286baa9234b15227039c5445190&pid=1-s2.0-S2772974523000182-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138549343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lower Urinary Tract Symptoms (LUTS) and COVID-19 下尿路症状(LUTS)与COVID-19
Continence Reports Pub Date : 2023-12-01 DOI: 10.1016/j.contre.2023.100044
Sona Tayebi , Mohammad Sajjad Rahnama’i , Ashkan Shafigh , Hanieh Salehi-Pourmehr , Hadi Mostafaei , Ehsan Sepehran , Sakineh Hajebrahimi
{"title":"Lower Urinary Tract Symptoms (LUTS) and COVID-19","authors":"Sona Tayebi ,&nbsp;Mohammad Sajjad Rahnama’i ,&nbsp;Ashkan Shafigh ,&nbsp;Hanieh Salehi-Pourmehr ,&nbsp;Hadi Mostafaei ,&nbsp;Ehsan Sepehran ,&nbsp;Sakineh Hajebrahimi","doi":"10.1016/j.contre.2023.100044","DOIUrl":"https://doi.org/10.1016/j.contre.2023.100044","url":null,"abstract":"<div><p>The COVID-19 has been a great challenge for healthcare providers all over the world which overwhelmed patients and healthcare providers by postponing many outpatient appointments and surgical procedures for months. Interestingly, COVID-19 can cause de novo lower urinary tract symptoms (LUTS) in some affected patients or exacerbate underlying LUTS in others although the most prevalent symptoms are respiratory symptoms. Understanding the effects of COVID-19 on LUTS is crucial for establishing bladder inflammation. In this review, we are focusing on how the lower urinary tract would be affected by COVID-19, considering the pathophysiology, and clinical implication of COVID-19-associated LUTS.</p></div>","PeriodicalId":100330,"journal":{"name":"Continence Reports","volume":"9 ","pages":"Article 100044"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S277297452300025X/pdfft?md5=4f9f7a9fec0290eee41708ddfac25d41&pid=1-s2.0-S277297452300025X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138467172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel finding: Proteinuria in patients with a urinary diversion does not predict renal function decline 新发现:尿分流患者的蛋白尿不能预测肾功能下降
Continence Reports Pub Date : 2023-11-07 DOI: 10.1016/j.contre.2023.100043
E.J.O. Claessens , P.D. Polm , M.B. Rookmaaker , L.M.O. de Kort
{"title":"Novel finding: Proteinuria in patients with a urinary diversion does not predict renal function decline","authors":"E.J.O. Claessens ,&nbsp;P.D. Polm ,&nbsp;M.B. Rookmaaker ,&nbsp;L.M.O. de Kort","doi":"10.1016/j.contre.2023.100043","DOIUrl":"10.1016/j.contre.2023.100043","url":null,"abstract":"<div><h3>Purpose:</h3><p>Proteinuria is used to track down patients with intrinsic renal disease and increased risk of renal function decline and is seen in up to 5% in the general population. The aim of this study is to investigate the prevalence and clinical relevance of proteinuria regarding renal function in patients with a urinary diversion.</p></div><div><h3>Methods:</h3><p>Data was collected of patients with a urinary diversion who had a follow-up appointment (T1) in the Urology Department of the University Hospital Utrecht in 2021. Patients were divided into a proteinuria and no proteinuria group. Proteinuria was determined through dipstick urinalysis at T1. Glomerular filtration rate and renal imaging were analysed at T1 and after 11–30 months follow-up (T2).</p></div><div><h3>Results:</h3><p>A research population of 84 patients was identified, median age was 38 years, 39.3% was male. At T1, 43% had proteinuria. There was no association between proteinuria and glomerular filtration rate nor abnormalities on renal imaging at T1 or T2. No statistically significant difference was seen in the glomerular filtration rate decline after 11–30 months between the group with and without proteinuria, determined at T1 (respectively 1.3 ± 6.9 ml/min/1.73 m<sup>2</sup> vs 2.3 ± 9.5 ml/min/1.73 m<sup>2</sup>; <span><math><mi>p</mi></math></span>-value 0.63).</p></div><div><h3>Conclusion:</h3><p>The prevalence of proteinuria in patients with a urinary diversion is high. Proteinuria was not associated with renal function or renal function decline over time. These findings illustrate the limitations of proteinuria screening to identify individuals at risk for renal function decline among this population.</p></div>","PeriodicalId":100330,"journal":{"name":"Continence Reports","volume":"8 ","pages":"Article 100043"},"PeriodicalIF":0.0,"publicationDate":"2023-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772974523000248/pdfft?md5=6e9477748defb76364d0f4c0762134f7&pid=1-s2.0-S2772974523000248-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135510593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信